According to a recent LinkedIn post from Function Health, the company is emphasizing the importance of testing insulin levels in addition to glucose to detect early metabolic changes. The post notes that glucose readings can appear normal for years even as insulin rises, suggesting that single-metric screening may miss emerging metabolic risk.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post highlights that Function Health members receive insulin and glucose testing as part of a broader panel of more than 160 lab tests. For investors, this focus on comprehensive metabolic assessment may indicate a differentiated positioning in preventive and personalized health, potentially supporting higher perceived value, customer retention, and pricing power in a competitive digital health and diagnostics market.